Ann Kessler

Ann Clare Kessler is currently the Director at EyeTracking, Inc. and a Member-Supervisory Board at EraCal Therapeutics AG.
She has previously worked as a Director at Spectrum Pharmaceuticals, Inc., MedGenesis Therapeutix, Inc., AltheaDx, Inc., CroMedica Global, Inc., and Scripps Translational Science Institute.
She was also the Head-Global Project Management at F.
Hoffmann-La Roche Ltd. from 1990 to 1995 and the Vice President & Head-Exploratory Research at Hoffmann-La Roche, Inc. from 1969 to 1989.
Dr. Kessler has also served as a Member-Supervisory Board at Gen-Probe, Inc. and Epigenomics AG.
She completed her undergraduate degree from Notre Dame of Maryland College OF in 1965, her graduate degree from Northwestern University in 1967, and her doctorate from New York University in 1973.